Bluthenthal Ricky N, Heinzerling Keith G, Anderson Rachel, Flynn Neil M, Kral Alex H
Health Program and Drug Policy Research Center, Rand Corp, 1776 Main S, PO Box 2138, Santa Monica, CA 90407-2138, USA.
Am J Public Health. 2008 Feb;98(2):278-83. doi: 10.2105/AJPH.2005.080770. Epub 2007 May 30.
We studied the effect of local approval of syringe exchange programs in California (through Assembly AB136) on program availability and performance.
We determined the number of active syringe exchange programs in California by conducting Internet searches and obtaining information from the state and from local programs. To track changes in program availability and performance between 2000 and 2002, we interviewed 24 program directors annually for 3 years about program characteristics, syringe exchange policies, law enforcement contact, and other issues. We conducted multivariate analyses to determine whether AB136 approval status was associated with changes in performance.
Fifteen local governments (13 counties and 2 cities) enacted the new law by 2002, and operating syringe exchange programs increased from 24 to 35. The proportion of these programs that were not locally approved declined from 54% to 40%. No new approved programs were started in high-need counties. Total syringes exchanged increased by more than 1 million per year, average annual budgets increased by more than 50%, and police harassment of the program volunteers, clients, and operators declined. Improvements at approved syringe exchange programs accounted for these changes.
Statewide approval and funding appears necessary to further syringe exchange availability in California.
我们研究了加利福尼亚州注射器交换项目通过州议会法案AB136获得地方批准对项目可及性和运行情况的影响。
我们通过互联网搜索并从州政府及地方项目获取信息,确定了加利福尼亚州活跃的注射器交换项目数量。为追踪2000年至2002年间项目可及性和运行情况的变化,我们在3年时间里每年采访24位项目主管,询问项目特征、注射器交换政策、与执法部门的联系及其他问题。我们进行了多变量分析,以确定AB136的批准状态是否与运行情况的变化相关。
到2002年,15个地方政府(13个县和2个市)颁布了新法律,运行的注射器交换项目从24个增加到35个。这些未获得地方批准的项目比例从54%降至40%。需求高的县没有启动新的获批项目。每年交换的注射器总数增加了100多万支,平均年度预算增加了50%以上,警方对项目志愿者、客户和运营者的骚扰减少。获批注射器交换项目的改善带来了这些变化。
全州范围的批准和资金投入似乎是进一步提高加利福尼亚州注射器交换项目可及性所必需的。